Brenntag (BNR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
19 May, 2026Executive summary
Q1 2026 began with subdued demand and weak market activity, but momentum improved from mid-March due to agile crisis management, commercial agility, and pricing actions following Middle East disruptions.
Integrated business model and organizational simplification enabled reliable supply, value creation, and cost-out savings of EUR 27 million in Q1.
The acquisition of Airedale Group in the UK was completed, strengthening EMEA presence and enhancing service capabilities.
The company remains focused on organic growth, commercial execution, and leveraging its full product portfolio.
Financial highlights
Q1 2026 sales were EUR 3.7 billion, down 5.1% year-over-year (fx adjusted); operating gross profit was EUR 950 million, down 1.3%, with gross margin up 0.9pp to 25.9%.
Operating EBITDA was EUR 306 million, down 8.3% year-over-year; profit after tax was EUR 98–99 million; EPS was EUR 0.68 (Q1 2025: EUR 0.93).
Free cash flow was EUR 91 million, down from EUR 163 million in Q1 2025, impacted by higher working capital needs.
Cost-out program delivered EUR 27 million in Q1, with OpEx down year-over-year.
Outlook and guidance
Full-year 2026 operating EBITDA guidance is confirmed at EUR 1,150–1,350 million, reflecting robust YTD performance and ongoing uncertainties.
Q2 is expected to progress well, but H2 demand remains uncertain due to macroeconomic and geopolitical risks; supply chains may normalize within 6–12 months if tensions ease.
Strategy update planned for Capital Markets Day on November 12, 2026.
Latest events from Brenntag
- Resilient Q1 2026 results, strong margins, and confirmed 2026 EBITDA guidance amid market volatility.BNR
Investor presentation13 May 2026 - Gross margin and cash flow rose despite lower earnings, with cost savings and cautious outlook.BNR
Q4 202525 Apr 2026 - Resilient FY 2024 performance with strong cash flow, cost-out, and sustainability leadership.BNR
Investor presentation12 Mar 2026 - Board renewal, enhanced remuneration, and ESG leadership drive governance excellence.BNR
Investor presentation17 Feb 2026 - Q2 and H1 2024 saw lower sales, EBITA, and cash flow, with guidance revised down.BNR
Q2 20241 Feb 2026 - Sales and gross profit rose, but EBITA, EPS, and free cash flow declined; guidance reaffirmed.BNR
Q3 202414 Jan 2026 - Sales and EBITA fell, but free cash flow and cost savings improved; guidance at lower end.BNR
Q3 202512 Dec 2025 - Sales and EBITDA fell, but cost savings and M&A support stability amid tough markets.BNR
Q4 20244 Dec 2025 - Stable Q1 sales and profit, but net income and cash flow declined amid global uncertainty.BNR
Q1 202524 Nov 2025